OST-HER2 Yields Significant Survival in Pulmonary Metastatic Osteosarcoma
Written by
Cancer Network
Published
0
comments
0
min
Phase 2b findings demonstrate improved 2-year survival outcomes with OST-HER2 compared with historical control data.